-
Signature
-
/s/ Paul Breaux, by Power of Attorney for Mark W. Jenkins
-
Issuer symbol
-
CVNA
-
Transactions as of
-
01 Dec 2025
-
Net transactions value
-
-$5,028,643
-
Form type
-
4
-
Filing time
-
02 Dec 2025, 18:51:16 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| JENKINS MARK W. |
Chief Financial Officer |
C/O CARVANA CO., 300 E. RIO SALADO PKWY, TEMPE |
/s/ Paul Breaux, by Power of Attorney for Mark W. Jenkins |
02 Dec 2025 |
0001700540 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CVNA |
Class A Common Stock |
Tax liability |
$457,442 |
-1,219 |
-0.59% |
$375.26 |
204,923 |
01 Dec 2025 |
Direct |
F1 |
| transaction |
CVNA |
Class A Common Stock |
Options Exercise |
$100,700 |
+10,000 |
+4.9% |
$10.07 |
214,923 |
01 Dec 2025 |
Direct |
F2 |
| transaction |
CVNA |
Class A Common Stock |
Options Exercise |
$84,060 |
+2,000 |
+0.93% |
$42.03 |
216,923 |
01 Dec 2025 |
Direct |
F2 |
| transaction |
CVNA |
Class A Common Stock |
Options Exercise |
$38,978 |
+750 |
+0.35% |
$51.97 |
217,673 |
01 Dec 2025 |
Direct |
F2 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$14,815 |
-40 |
-0.02% |
$370.38 |
217,633 |
01 Dec 2025 |
Direct |
F2 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$1,128,220 |
-3,030 |
-1.4% |
$372.35 |
214,603 |
01 Dec 2025 |
Direct |
F2, F3, F4 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$222,636 |
-596 |
-0.28% |
$373.55 |
214,007 |
01 Dec 2025 |
Direct |
F2, F3, F5 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$437,533 |
-1,168 |
-0.55% |
$374.60 |
212,839 |
01 Dec 2025 |
Direct |
F2, F3, F6 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$649,037 |
-1,728 |
-0.81% |
$375.60 |
211,111 |
01 Dec 2025 |
Direct |
F2, F3, F7 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$505,061 |
-1,341 |
-0.64% |
$376.63 |
209,770 |
01 Dec 2025 |
Direct |
F2, F3, F8 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$411,595 |
-1,090 |
-0.52% |
$377.61 |
208,680 |
01 Dec 2025 |
Direct |
F2, F3, F9 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$631,455 |
-1,668 |
-0.8% |
$378.57 |
207,012 |
01 Dec 2025 |
Direct |
F2, F3, F10 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$367,726 |
-969 |
-0.47% |
$379.49 |
206,043 |
01 Dec 2025 |
Direct |
F2, F3, F11 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$304,720 |
-800 |
-0.39% |
$380.90 |
205,243 |
01 Dec 2025 |
Direct |
F2, F3, F12 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$122,141 |
-320 |
-0.16% |
$381.69 |
204,923 |
01 Dec 2025 |
Direct |
F2, F3, F13 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CVNA |
Stock Options (Right to Buy) |
Options Exercise |
$0 |
-10,000 |
-5.3% |
$0.000000 |
178,513 |
01 Dec 2025 |
Class A Common Stock |
10,000 |
$10.07 |
Direct |
F2, F14 |
| transaction |
CVNA |
Stock Options (Right to Buy) |
Options Exercise |
$0 |
-2,000 |
-3.4% |
$0.000000 |
56,703 |
01 Dec 2025 |
Class A Common Stock |
2,000 |
$42.03 |
Direct |
F2, F15 |
| transaction |
CVNA |
Stock Options (Right to Buy) |
Options Exercise |
$0 |
-750 |
-3.4% |
$0.000000 |
21,596 |
01 Dec 2025 |
Class A Common Stock |
750 |
$51.97 |
Direct |
F2, F15 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: